A carregar...
SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report
Euglycemic diabetic ketoacidosis is a rare but serious adverse effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We present a case of a woman in her 40s with type 2 diabetes mellitus hospitalized for revascularization for moyamoya disease who developed empagliflozin-associated euglycemic...
Na minha lista:
| Publicado no: | Kidney Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380362/ https://ncbi.nlm.nih.gov/pubmed/32734242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.12.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|